775 related articles for article (PubMed ID: 30522805)
1. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
3. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
[TBL] [Abstract][Full Text] [Related]
4. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
[TBL] [Abstract][Full Text] [Related]
6. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
[TBL] [Abstract][Full Text] [Related]
7. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
[TBL] [Abstract][Full Text] [Related]
8. Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.
Lo Iacono M; Anzalone R; La Rocca G; Baiamonte E; Maggio A; Acuto S
Stem Cell Rev Rep; 2017 Feb; 13(1):35-49. PubMed ID: 27853939
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
[TBL] [Abstract][Full Text] [Related]
10. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
12. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
[TBL] [Abstract][Full Text] [Related]
13. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
Bakhshi T; Zabriskie RC; Bodie S; Kidd S; Ramin S; Paganessi LA; Gregory SA; Fung HC; Christopherson KW
Transfusion; 2008 Dec; 48(12):2638-44. PubMed ID: 18798803
[TBL] [Abstract][Full Text] [Related]
16. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures.
Julavijitphong S; Wichitwiengrat S; Tirawanchai N; Ruangvutilert P; Vantanasiri C; Phermthai T
Cytotherapy; 2014 May; 16(5):683-91. PubMed ID: 24119645
[TBL] [Abstract][Full Text] [Related]
17. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
18. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.
Iacono E; Brunori L; Pirrone A; Pagliaro PP; Ricci F; Tazzari PL; Merlo B
Reproduction; 2012 Apr; 143(4):455-68. PubMed ID: 22274885
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
